Overview

Update
Status
Acquired by on July 2, 2010
Total Equity Funding
$55M in 2 Rounds from 4 Investors
Headquarters:
Cambridge, MA
Description:
Alnara Pharmaceuticals develops and commercializes orally-delivered protein therapeutics for the treatment of metabolic diseases.
Founders:
, ,
Categories:
Pharmaceutical, Therapeutics, Health Care
Website:
http://www.alnara.com

Company Details

Update

Alnara Pharmaceuticals, Inc. is dedicated to developing novel protein therapeutics for the treatment of metabolic diseases. The company's innovative approach focuses on designing effective protein therapies that can be orally delivered directly to the gastrointestinal tract without being absorbed into the bloodstream.

Funding Rounds (2) - $55M

Update
DateAmount / RoundValuationLead InvestorInvestors
Jan, 2010$35M / Series B1
Oct, 2008$20M / Series A3

Current Team (1)

Update

Offices/Locations (1)

Update
  • Headquarters

    840 Memorial Drive

    Cambridge, MA 02139

    USA

Past Team (6)

Update

Images (1)

Update

Add Acquisitions

Add Board Members and Advisors

Add Products

Add Sub Organizations

Add Competitors

Add Memberships

Add Customers

Add Partners

Add Videos